BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38131308)

  • 1. Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
    Nolan J; Buchanan J; Taylor J; Almeida J; Bedenham T; Blair E; Broadgate S; Butler S; Cazeaux A; Craft J; Cranston T; Crawford G; Forrest J; Gabriel J; George E; Gillen D; Haeger A; Hastings Ward J; Hawkes L; Hodgkiss C; Hoffman J; Jones A; Karpe F; Kasperaviciute D; Kovacs E; Leigh S; Limb E; Lloyd-Jani A; Lopez J; Lucassen A; McFarlane C; O'Rourke AW; Pond E; Sherman C; Stewart H; Thomas E; Thomas S; Thomas T; Thomson K; Wakelin H; Walker S; Watson M; Williams E; Ormondroyd E
    Genet Med; 2024 Mar; 26(3):101051. PubMed ID: 38131308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional findings from the 100,000 Genomes Project: A qualitative study of recipient perspectives.
    Nolan JJ; Forrest J; Ormondroyd E
    Genet Med; 2024 Feb; 26(6):101103. PubMed ID: 38411041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
    Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
    Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of inherited cancer susceptibility syndromes.
    Brown GR; Simon M; Wentling C; Spencer DM; Parker AN; Rogers CA
    JAAPA; 2020 Dec; 33(12):10-16. PubMed ID: 33234888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
    Silva E; Gomes P; Matos PM; Silva ER; Silva J; Brandão C; Castro F; Neves MC; Sales CMD
    BMC Prim Care; 2022 Apr; 23(1):93. PubMed ID: 35461227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational study of population genomic screening for variants associated with endocrine tumor syndromes in a large, healthcare-based cohort.
    Savatt JM; Ortiz NM; Thone GM; McDonald WS; Kelly MA; Berry ASF; Alvi MM; Hallquist MLG; Malinowski J; Purdy NC; Williams MS; Sturm AC; Buchanan AH
    BMC Med; 2022 Jun; 20(1):205. PubMed ID: 35668420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands.
    Dommering CJ; Henneman L; van der Hout AH; Jonker MA; Tops CM; van den Ouweland AM; van der Luijt RB; Mensenkamp AR; Hogervorst FB; Redeker EJ; de Die-Smulders CE; Moll AC; Meijers-Heijboer H
    Fam Cancer; 2017 Apr; 16(2):271-277. PubMed ID: 27826806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of a genomic screening program for actionable genetic conditions.
    Buchanan AH; Lester Kirchner H; Schwartz MLB; Kelly MA; Schmidlen T; Jones LK; Hallquist MLG; Rocha H; Betts M; Schwiter R; Butry L; Lazzeri AL; Frisbie LR; Rahm AK; Hao J; Willard HF; Martin CL; Ledbetter DH; Williams MS; Sturm AC
    Genet Med; 2020 Nov; 22(11):1874-1882. PubMed ID: 32601386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.
    Rich TA; Liu M; Etzel CJ; Bannon SA; Mork ME; Ready K; Saraiya DS; Grubbs EG; Perrier ND; Lu KH; Arun BK; Woodard TL; Schover LR; Litton JK
    Fam Cancer; 2014 Jun; 13(2):291-9. PubMed ID: 24072553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynch syndrome and MYH-associated polyposis: review and testing strategy.
    Goodenberger M; Lindor NM
    J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Management of Hereditary Pancreatic Cancer.
    Humphris JL; Biankin AV
    Recent Results Cancer Res; 2016; 205():61-83. PubMed ID: 27075349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
    Nazareth S; Hayward L; Simmons E; Snir M; Hatchell KE; Rojahn S; Slotnick RN; Nussbaum RL
    Obstet Gynecol; 2021 Dec; 138(6):860-870. PubMed ID: 34735417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.